NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

腋下多汗症:2030年前的流行病學預測

Axillary Hyperhidrosis - Epidemiology Insight - 2030

出版商 DelveInsight Business Research LLP 商品編碼 966755
出版日期 按訂單生產 內容資訊 英文 50 Pages
商品交期: 10個工作天內
價格
腋下多汗症:2030年前的流行病學預測 Axillary Hyperhidrosis - Epidemiology Insight - 2030
出版日期: 按訂單生產內容資訊: 英文 50 Pages
簡介

本報告提供美國,德國,法國,義大利,西班牙,英國,日本等主要7個國家的腋下多汗症的流行病學相關市場調查,提供疾病的背景和概要,流行病學與患者數,目前治療方法,主要專家的見解,未滿足需求等資訊。

目錄

第1章 主要調查結果

第2章 摘要整理

第3章 疾病的背景和概要

  • 簡介
  • 徵兆與症狀
  • 病理學
  • 危險因素
  • 診斷

第4章 患者的治療過程

第5章 流行病學和患者數

  • 主要調查結果
  • 前提和根據:主要7個國家
  • 流行病學方案:主要7個國家
    • 主要7個國家的流行病學方案
  • 美國
  • 歐洲5個國家
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
  • 日本

第6章 治療流程,目前治療和醫療

  • 治療和管理
  • 治療流程

第7章 主要專家的見解

第8章 未滿足需求

第9章 附錄

  • 參考文獻
  • 報告的調查手法

第10章 DelveInsight的服務內容

第11章 免責聲明

第12章 關於DelveInsight

目錄
Product Code: DIEI1030

DelveInsight's 'Axillary Hyperhidrosis (AH)-Epidemiology Forecast-2030' report delivers an in-depth understanding of the Axillary Hyperhidrosis (AH), historical and forecasted epidemiology as well as the Axillary Hyperhidrosis (AH) trends in the United States.

Axillary Hyperhidrosis (AH) Disease Understanding

Axillary hyperhidrosis, a form of excessive sweating from armpits, is a disease that affects the social and occupational lives of many people on all continents. Axillary hyperhidrosis begins during the teenage years and equally affects men and women. Hyperhidrosis initially begins from the hands and feet during early childhood, whereas axillary hyperhidrosis often starts in adolescence. When associated with axillary malodor, it is known as bromhidrosis. The sweat glands-small tubular structures in the skin-secrete sweat onto the skin via a duct. Eccrine sweat glands are distributed throughout the body, and they secrete sweat directly onto the surface of the skin. Apocrine sweat glands are 10 times larger than eccrine sweat glands. They are localized in the axilla (underarms) and perianal areas.

The various causes of hyperhidrosis can be compounded by anxiety and stress. They can range from moderate moisture to severe dripping, which can, in turn, exacerbate the associated anxiety and stress. Excessive armpit sweating may be caused by genetic predisposition, medications, neurologic/metabolic, or other systemic diseases, hormonal changes such as menopause, social anxiety, stress, nervousness, or unknown factors.

Axillary Hyperhidrosis (AH) Epidemiology Perspective by DelveInsight

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Total Prevalent Cases of Axillary Hyperhidrosis, Diagnosed Prevalence of Axillary Hyperhidrosis, Age-specific Diagnosed Prevalent Cases of Axillary Hyperhidrosis, Type-specific Diagnosed Prevalent Cases of Axillary Hyperhidrosis, Severity-specific Diagnosed Prevalent Cases of Axillary Hyperhidrosis in the United States from 2017 to 2030.

Axillary Hyperhidrosis (AH) Detailed Epidemiology Segmentation

  • As per DelveInsight's analysis, there was a total of 10,162,438 Axillary Hyperhidrosis prevalent cases in 2017.
  • As per DelveInsight's analysis, a total of 3,048,732 Axillary Hyperhidrosis cases were diagnosed in 2017.
  • In 2017, 327,129 cases accounted for <18 years, 1,635,035 cases for 18-39 years, 872,852 cases for 40-64 years and (213,716) remaining cases for 65+ years.
  • As per DelveInsight's analysis, a total of 3,048,732 Axillary Hyperhidrosis cases were diagnosed in 2017, Out of which 93% accounted for Primary hyperhidrosis and 7% accounted for secondary hyperhidrosis.
  • As per DelveInsight's analysis, 3,048,732 Axillary Hyperhidrosis cases were diagnosed in 2017, out of which 52% accounted for severe HDSS scale 3 or 4 and 48% accounted for Non-severe HDSS scale 1 or 2.

Scope of the Report:

  • The report covers the descriptive overview of Axillary Hyperhidrosis (AH), explaining its signs and symptoms, and pathophysiology.
  • The report provides insight into the United States historical and forecasted patient pool.
  • The report assesses the disease risk and burden and highlights the unmet needs of Axillary Hyperhidrosis (AH).
  • The report helps to recognize the growth opportunities in the United States with respect to the patient population.
  • The report provides the segmentation of the disease epidemiology for United States by Total Pravelent Cases of Axillary Hyperhidrosis (AH), Gender-specific Incident Cases of Axillary Hyperhidrosis (AH), Diagnosed Prevalence of Axillary Hyperhidrosis, Age-specific Diagnosed Prevalent Cases of Axillary Hyperhidrosis, Type-specific Diagnosed Prevalent Cases of Axillary Hyperhidrosis, Severity-specific Diagnosed Prevalent Cases of Axillary Hyperhidrosis.

Report Highlights:

  • 11-Year Forecast of Axillary Hyperhidrosis (AH)
  • United States Coverage
  • Total Pravelent Cases of Axillary Hyperhidrosis (AH)
  • Diagnosed Prevalence of Axillary Hyperhidrosis
  • Age-specific Diagnosed Prevalent Cases of Axillary Hyperhidrosis
  • Type-specific Diagnosed Prevalent Cases of Axillary Hyperhidrosis
  • Severity-specific Diagnosed Prevalent Cases of Axillary Hyperhidrosis

Key Questions Answered

  • What are the disease risk, burdens, and unmet needs of Axillary Hyperhidrosis (AH)?
  • What is the historical Axillary Hyperhidrosis (AH) patient pool in the United States?
  • What would be the forecasted patient pool of Axillary Hyperhidrosis (AH) at the United States level?
  • What will be the growth opportunities across the United States with respect to the patient population pertaining to Axillary Hyperhidrosis (AH)?
  • At what CAGR the population is expected to grow across the United States during the forecast period (2020-2030)?

Reasons to buy:

The Axillary Hyperhidrosis (AH) report will allow the user to -

  • Develop business strategies by understanding the trends shaping and driving the United States Axillary Hyperhidrosis (AH) epidemiology forecast.
  • The Axillary Hyperhidrosis (AH) epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists.
  • The Axillary Hyperhidrosis (AH) epidemiology model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over the eleven-year forecast period using reputable sources.

Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

Geographies Covered

  • The United States

Study Period: 2017-2030

Table of Contents

1 Key Insights

2 Executive Summary of Axillary Hyperhidrosis (AH)

3 Disease Background and Overview: Axillary Hyperhidrosis

  • 3.1. Introduction
  • 3.2. Types and Underlying Causes of Hyperhidrosis
  • 3.3. Symptoms of Axillary hyperhidrosis
  • 3.4. Pathophysiology of Axillary hyperhidrosis
  • 3.5. Diagnosis
    • 3.5.1. Diagnostic Algorithm

4 Patient Journey

5 Epidemiology and Patient Population

  • 5.1 Key Findings
  • 5.2 KOL Views
  • 5.3 Epidemiology Methodology
  • 5.4 Assumptions and Rationale
  • 5.5 Total Prevalent Cases of Axillary Hyperhidrosis in the United States
  • 5.6 Diagnosed Prevalent Cases of Axillary Hyperhidrosis in the United States
  • 5.7 Age-specific Diagnosed Prevalent Cases of Axillary Hyperhidrosis in the United States
  • 5.8 Type-Specific Diagnosed Prevalent Cases of Axillary Hyperhidrosis in the United States
  • 5.9 Severity Specific Diagnosed Prevalent Cases of Axillary Hyperhidrosis in the United States

6 Appendix

  • 6.1 Bibliography
  • 6.2 Report Methodology

7 DelveInsight Capabilities

8 Disclaimer

9 About DelveInsight

List of Tables

  • Table 1 Summary of Axillary Hyperhidrosis Epidemiology and Key Events (2017-2030)
  • Table 2 Sweating rates by gravimetric measurement
  • Table 3 Hyperhidrosis Disease Severity Scale (HDSS)
  • Table 4 Total Prevalent Cases of Axillary Hyperhidrosis in the US (2017-2030)
  • Table 5 Diagnosed Prevalent Cases of Axillary Hyperhidrosis in the US (2017-2030)
  • Table 6 Age-Specific Diagnosed Prevalent Cases of Axillary Hyperhidrosis in the US (2017-2030)
  • Table 7 Type-Specific Diagnosed Prevalent Cases of Axillary Hyperhidrosis in the US (2017-2030)
  • Table 8 Severity-Specific Diagnosed Prevalent Cases of Axillary Hyperhidrosis in the US (2017-2030)

List of Figures

  • Figure 1 Summary of Axillary Hyperhidrosis Epidemiology and Key Events (2017-2030)
  • Figure 2 Sweating rates by gravimetric measurement
  • Figure 3 Hyperhidrosis Disease Severity Scale (HDSS)
  • Figure 4 Total Prevalent Cases of Axillary Hyperhidrosis in the US (2017-2030)
  • Figure 5 Diagnosed Prevalent Cases of Axillary Hyperhidrosis in the US (2017-2030)
  • Figure 6 Age-Specific Diagnosed Prevalent Cases of Axillary Hyperhidrosis in the US (2017-2030)
  • Figure 7 Type-Specific Diagnosed Prevalent Cases of Axillary Hyperhidrosis in the US (2017-2030)
  • Figure 8 Severity-Specific Diagnosed Prevalent Cases of Axillary Hyperhidrosis in the US (2017-2030)